Dr. Anil Mandhani

• Dr. Anil Mandhani is a well-known Urologist, practicing successfully for more than 25 years.


• He did more than 550 successful robotic surgeries and more than 1000 kidney transplants.


• He has also been known for managing complex situations emanating from deviant outcomes of surgery done by others.


• His areas of specialization are Uro-Oncology, Robotic Surgery, and Kidney Transplant.


• After completing his MBBS in 1990, he did MS in General Surgery in 1993 from Pt. JNM Medical College, Ravi Shankar University, Raipur, India.


• After that, he did MCh in Urology from Sanjay Gandhi Post Graduate Institue of Medical Sciences, Lucknow, in 1998, Diplomat of National Board in Urology from the National Board Examination of India in 1998, and gained Clinical Fellowship in Uro-oncology from Cornell/New York Presbyterian Hospital in 2007.


• He is the Associate Editor of the Indian Journal of Urology.


• He has over 200 publications in national and international journals.


• He is a well-known member of the American Urological Association, European Urological Association, British Association of Urological Surgeons, and Indian Urological Association.

Best paper award on 'prediction of Fragility of stone by DEXA' in the national conference of Urology 2003.
"Innovation Award" by Urological Society of India for "Endopyelotomy sheath: a new device to facilitate antegrade Endopyelotomy".
International Guest Scholarship by American College of Surgeons in 2010.
Awarded Fellow of American College of Surgeon, FACS in 2012
DUSUCON award on best clinical work on PSA characteristic in prostate cancer. 2013
DUSUCON North zone urological society of India for best research work award. 2014
Awarded with best reviewer by Journal of Urology in 2017.

... Read Less

• Associated with clinical and basic research on managing various cancers in Urology and has published papers in noted national and international medical journals. These are: ICMR :   To study the impact of chronic asymptomatic Prostatitis on serum PSA level measuring seminal fluid interleukin-8 levels and its gene polymorphism


• UPCST:   Expression of androgen receptors at various stages of metastatic prostatic cancer and correlation with response pattern to ADT


• Cancer research grant from Pfizer: Correlation of natural killer cell counts in whole blood and human leukocyte and antigen-g expression in tumor tissue of renal cell carcinoma patients.


• Cancer research grant from Pfizer: Finding targets of micro RNA by western blot techniques in bladder cancer


• Cancer research grant from Pfizer: Assessment of micro RNA expression and validation of its utility as a new marker of prognosticating the outcome of bladder cancer


• Cancer research grant from Pfizer: Prediction of stone fragility by dual energy x-ray absorptiometry


• Cancer research grant from Pfizer: Renal cell carcinoma in India present at an early age and in advanced stage


• Toxicol Int: Tobacco exposure may enhance inflammation in prostate carcinoma patients, an explorative study in North Indian population, in 2012


• Indian J Urol: Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines? 2012


• Indian J Urol: Does en-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen?, 2012